Oliver Coutelle

1.9k total citations
25 papers, 1.4k citations indexed

About

Oliver Coutelle is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Oliver Coutelle has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Genetics. Recurrent topics in Oliver Coutelle's work include Angiogenesis and VEGF in Cancer (10 papers), Virus-based gene therapy research (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Oliver Coutelle is often cited by papers focused on Angiogenesis and VEGF in Cancer (10 papers), Virus-based gene therapy research (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Oliver Coutelle collaborates with scholars based in Germany, United Kingdom and United States. Oliver Coutelle's co-authors include Michael Hallek, André Rosenthal, Molly Craxton, Hildegard Büning, Peter Rigby, Hamid Kashkar, Luca Perabò, Ulrich Hacker, Margarete Odenthal and Richard Hampson and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Oliver Coutelle

23 papers receiving 1.4k citations

Peers

Oliver Coutelle
Lisa Dillard‐Telm United States
Hua Chang United States
David Lapointe United States
Cheng‐Keat Tan United States
Jacques Bollekens United States
Mamatha Mahadevappa United States
Oliver Coutelle
Citations per year, relative to Oliver Coutelle Oliver Coutelle (= 1×) peers Tomoko Takahashi

Countries citing papers authored by Oliver Coutelle

Since Specialization
Citations

This map shows the geographic impact of Oliver Coutelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Coutelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Coutelle more than expected).

Fields of papers citing papers by Oliver Coutelle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Coutelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Coutelle. The network helps show where Oliver Coutelle may publish in the future.

Co-authorship network of co-authors of Oliver Coutelle

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Coutelle. A scholar is included among the top collaborators of Oliver Coutelle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Coutelle. Oliver Coutelle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schiffmann, Lars M., Melanie Fritsch, Saskia Diana Günther, et al.. (2020). Mitochondrial respiration controls neoangiogenesis during wound healing and tumour growth. Nature Communications. 11(1). 53 indexed citations
2.
Schiffmann, Lars M., Melanie Fritsch, Florian Gebauer, et al.. (2018). Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancer. British Journal of Cancer. 120(1). 69–78. 63 indexed citations
3.
Schiffmann, Lars M., Valentin Goede, Sonja Loges, et al.. (2017). A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition. British Journal of Cancer. 116(5). 600–608. 28 indexed citations
4.
Hacker, Ulrich, Valentin Goede, Lars M. Schiffmann, et al.. (2016). Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial. British Journal of Cancer. 114(8). 855–862. 39 indexed citations
5.
Witt, Axel, Jens M. Seeger, Oliver Coutelle, et al.. (2015). IAP antagonization promotes inflammatory destruction of vascular endothelium. EMBO Reports. 16(6). 719–727. 12 indexed citations
6.
Coutelle, Oliver, Lars M. Schiffmann, Valentin Goede, et al.. (2015). Dual targeting of Angiopoetin-2 and VEGF potentiates effective vascular normalisation without inducing empty basement membrane sleeves in xenograft tumours. British Journal of Cancer. 112(3). 495–503. 23 indexed citations
7.
Coutelle, Oliver, Hue‐Tran Hornig‐Do, Axel Witt, et al.. (2014). Embelin inhibits endothelial mitochondrial respiration and impairs neoangiogenesis during tumor growth and wound healing. EMBO Molecular Medicine. 6(5). 624–639. 65 indexed citations
8.
Brinkmann, Kerstin, Paola Zigrino, Axel Witt, et al.. (2013). Ubiquitin C-Terminal Hydrolase-L1 Potentiates Cancer Chemosensitivity by Stabilizing NOXA. Cell Reports. 3(3). 881–891. 62 indexed citations
9.
Goede, Valentin, Oliver Coutelle, Alexander Shimabukuro‐Vornhagen, et al.. (2011). Analysis of Tie2-Expressing Monocytes (TEM) in Patients With Colorectal Cancer. Cancer Investigation. 30(3). 225–230. 15 indexed citations
10.
Coutelle, Oliver, et al.. (2011). Successful target cell transduction of capsid-engineered rAAV vectors requires clathrin-dependent endocytosis. Gene Therapy. 19(2). 210–218. 38 indexed citations
11.
Kwiecinski, M, A Noetel, N Elfimova, et al.. (2011). Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction. PLoS ONE. 6(9). e24568–e24568. 123 indexed citations
12.
Seeger, Jens M., Patrick Schmidt, Kerstin Brinkmann, et al.. (2010). The Proteasome Inhibitor Bortezomib Sensitizes Melanoma Cells toward Adoptive CTL Attack. Cancer Research. 70(5). 1825–1834. 47 indexed citations
13.
Brinkmann, Kerstin, et al.. (2010). Elevated XIAP expression alone does not confer chemoresistance. British Journal of Cancer. 102(12). 1717–1723. 20 indexed citations
14.
Goede, Valentin, Oliver Coutelle, A. Reinacher-Schick, et al.. (2010). Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy. British Journal of Cancer. 103(9). 1407–1414. 142 indexed citations
15.
Kreppel, Florian, Marianna Hösel, Oliver Coutelle, et al.. (2010). Intrinsic phospholipase A2 activity of adeno-associated virus is involved in endosomal escape of incoming particles. Virology. 409(1). 77–83. 83 indexed citations
16.
Strack, I, Roswitha Nischt, Oliver Coutelle, et al.. (2010). Combined Paracrine and Endocrine AAV9 mediated Expression of Hepatocyte Growth Factor for the Treatment of Renal Fibrosis. Molecular Therapy. 18(7). 1302–1309. 39 indexed citations
17.
Weihrauch, Martin R., Dirk L. Stippel, Jochen W.U. Fries, et al.. (2008). Complete Remission in a Colon Cancer Patient with a Large, Irresectable Liver Metastasis after XELOX/Cetuximab/Bevacizumab Treatment. Onkologie. 31(8-9). 464–467. 2 indexed citations
18.
Büning, Hildegard, et al.. (2008). Recent developments in adeno‐associated virus vector technology. The Journal of Gene Medicine. 10(7). 717–733. 129 indexed citations
19.
Coutelle, Oliver, et al.. (2001). Hedgehog Signalling Is Required for Maintenance of myf5 and myoD Expression and Timely Terminal Differentiation in Zebrafish Adaxial Myogenesis. Developmental Biology. 236(1). 136–150. 129 indexed citations
20.
Rosenthal, André, Oliver Coutelle, & Molly Craxton. (1993). Large-scale production of DNA sequencing templates by microtitre format PCR. Nucleic Acids Research. 21(1). 173–174. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026